Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.
Fujimoto Y, Azuma YT, Matsuo Y, Kuwamura M, Kuramoto N, Miki M, Azuma N, Teramoto M, Nishiyama K, Izawa T, Nakajima H, Takeuchi T.
Fujimoto Y, et al. Among authors: kuwamura m.
Naunyn Schmiedebergs Arch Pharmacol. 2017 Mar;390(3):261-268. doi: 10.1007/s00210-016-1329-0. Epub 2016 Dec 9.
Naunyn Schmiedebergs Arch Pharmacol. 2017.
PMID: 27942772